|
14 Jan 2020 |
Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer
|
|
14 Jan 2020 |
Samsung Bioepis and AffaMed Therapeutics’ Eculizumab Biosimilar Candidate Receives China IND Approval, Expanding the Ongoing Global Phase 3 Trial
|
|
14 Jan 2020 |
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
|
|
14 Jan 2020 |
Allele and Astellas Enter into an Expanded License for the Development of iPSC Lines
|
|
13 Jan 2020 |
Allogene Therapeutics and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate ALLO-715 in Combination with Nirogacestat in Multiple Myeloma
|
|
13 Jan 2020 |
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
|
|
13 Jan 2020 |
Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)
|
|
13 Jan 2020 |
Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases
|
|
13 Jan 2020 |
Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma
|
|
13 Jan 2020 |
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma
|
|
13 Jan 2020 |
Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense
|
|
13 Jan 2020 |
Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)
|
|
13 Jan 2020 |
Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States
|
|
13 Jan 2020 |
Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer
|
|
13 Jan 2020 |
Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
|
|
13 Jan 2020 |
BioMarin, Pioneer in Phenylketonuria, to Begin Clinical Trial with BMN 307 Gene Therapy
|
|
13 Jan 2020 |
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
|
|
13 Jan 2020 |
Fauna Bio and Novo Nordisk enter into Research Collaboration to Discover Novel Therapeutics for Obesity
|
|
13 Jan 2020 |
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
|
|
13 Jan 2020 |
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
|
